Post by Weight Watchers

“GLP-1s are the catalyst, but the real goal is building scalable care models that address a lifelong journey, significantly shifting the trajectory of global chronic disease…” Thank you Hakim Yadi Ph.D. OBE for leading a dynamic conversation on this topic at this year’s health.tech | global summit and for sharing the helpful summary of the discussion between Novo Nordisk’s Vice President, Clinical, Medical & Regulatory Sebastian Meyhöfer and our Chief Medical Officer Kim Boyd, MD. Read Hakim’s key takeaways of the session here: https://lnkd.in/gpQ_Wfy5 #ObesityCare #GLP1 #DigitalHealth #ChronicDisease #HealthTech #NovoNordisk